BBIO BridgeBio Pharma, Inc.
Healthcare$67.73-2.01%ClosedMarket Cap: $13.27B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$105.15
Target (Median)
$100.00
Target Range
$83.00 - $157.00
Upside from current price: 55.2%
Rating Distribution
7 Strong Buy16 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-11 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-05-08 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-04-29 | Truist Securities | maintain | Buy | Buy |
| 2026-04-28 | Mizuho | maintain | Outperform | Outperform |
| 2026-03-18 | Mizuho | maintain | Outperform | Outperform |
| 2026-03-10 | JP Morgan | maintain | Overweight | Overweight |
| 2026-02-25 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-02-25 | Truist Securities | maintain | Buy | Buy |
| 2026-02-25 | Oppenheimer | maintain | Outperform | Outperform |
| 2026-02-25 | Morgan Stanley | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $0.62 | $1.60B | 12 |
| Sun Dec 31 | $3.66 | $2.40B | 14 |
| Mon Dec 31 | $7.00 | $3.35B | 8 |
| Tue Dec 31 | $9.44 | $4.25B | 12 |